Founded in 2004, ERYtech Pharma is a biotechnology company specialized in the encapsulation of therapeutic molecules or enzymes into red blood cells. The company targets the development of products indicated in the treatment of serious types of cancer, such as solid or haematological tumours, for which existing treatments are particularly constraining. ERYtech Pharma significantly improves the therapeutic index of the encapsulated molecules or enzymes and thus patients' life conditions. Since its creation, ERYtech Pharma has received support from several national institutions.